✦ LIBER ✦

484: New Development of Diabetes in Tacrolimus Treated Patients. Does It Really Matter?

✍ Scribed by G. Seebacher; A.Z. Aliabadi; S. Mahr; D. Dunkler; A. Fiala; A. Zuckermann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patients’ obstetric history in mid-trime

✍ Marco Scioscia; Antonella Vimercati; Giovanni Pontrelli; Luigi Nappi; Luigi Selv 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 349 KB

KCNQ1 gene variants and risk of new-onse

✍ Beatriz Tavira; Eliecer Coto; Carmen Díaz-Corte; Francisco Ortega; Manuel Arias; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Evolution of tacrolimus blood levels and

✍ Emilio Rodrigo; Celestino Piñera; María Angeles de Cos; Blanca Sánchez; Juan Car 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 99 KB

P.2.050 Varying degree of risks of devel

✍ F.G. Pajonk 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 275 KB

PMC39 WHAT DOES ACCEPTABILITY MEAN FOR P

✍ C Marant; J Longin; C Spizak; DL Patrick; C Saussier; B Arnould; E Van Ganse 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Mo-P5:325 Projected ability of lipid low

✍ Shavit, O.; Alemao, E.A.; Davies, G.M.; Yin, D.; Cook, J.R. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 152 KB